These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 33334936

  • 21. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A, Corradi M, Pigeon-Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, Fabbri LM, Rabe KF.
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [Abstract] [Full Text] [Related]

  • 22. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 23. Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial.
    Pilcher J, Patel M, Pritchard A, Thayabaran D, Ebmeier S, Shaw D, Black P, Braithwaite I, Weatherall M, Beasley R.
    NPJ Prim Care Respir Med; 2017 May 11; 27(1):33. PubMed ID: 28496190
    [Abstract] [Full Text] [Related]

  • 24. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun 11; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick(™) dry-powder inhaler in the treatment of asthma.
    Welch MJ.
    Expert Opin Drug Metab Toxicol; 2016 Sep 11; 12(9):1109-19. PubMed ID: 27424535
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
    Can Respir J; 1999 Sep 11; 6(1):45-51. PubMed ID: 10202220
    [Abstract] [Full Text] [Related]

  • 28. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
    Pavord ID, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, Williams M, Weatherall M, Beasley R, Novel START Study Team.
    Lancet Respir Med; 2020 Jul 11; 8(7):671-680. PubMed ID: 32171064
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.
    Health Technol Assess; 2001 Jul 11; 5(26):1-149. PubMed ID: 11701099
    [Abstract] [Full Text] [Related]

  • 30. Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Braithwaite I, Williams M, Power S, Pilcher J, Weatherall M, Baines A, Moynihan J, Kempsford R, Beasley R, FF/VI Study Team.
    Respir Med; 2016 Oct 11; 119():115-121. PubMed ID: 27692131
    [Abstract] [Full Text] [Related]

  • 31. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R, PRACTICAL study team.
    Lancet; 2019 Sep 14; 394(10202):919-928. PubMed ID: 31451207
    [Abstract] [Full Text] [Related]

  • 32. Does immediate smart feedback on therapy adherence and inhalation technique improve asthma control in children with uncontrolled asthma? A study protocol of the IMAGINE I study.
    Sportel ET, Oude Wolcherink MJ, van der Palen J, Lenferink A, Thio BJ, Movig KLL, Brusse-Keizer MGJ.
    Trials; 2020 Sep 17; 21(1):801. PubMed ID: 32943094
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Practice makes perfect: self-reported adherence a positive marker of inhaler technique maintenance.
    Azzi E, Srour P, Armour C, Rand C, Bosnic-Anticevich S.
    NPJ Prim Care Respir Med; 2017 Apr 24; 27(1):29. PubMed ID: 28439076
    [Abstract] [Full Text] [Related]

  • 36. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C, Wu EQ, Ray S, Colice GL.
    Clin Ther; 2009 Dec 24; 31(12):2779-803. PubMed ID: 20110019
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation.
    Müller V, Gálffy G, Eszes N, Losonczy G, Bizzi A, Nicolini G, Chrystyn H, Tamási L.
    BMC Pulm Med; 2011 Jul 15; 11():40. PubMed ID: 21762500
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial.
    Gregoriano C, Dieterle T, Breitenstein AL, Dürr S, Baum A, Giezendanner S, Maier S, Leuppi-Taegtmeyer A, Arnet I, Hersberger KE, Leuppi JD.
    Respir Res; 2019 Dec 03; 20(1):273. PubMed ID: 31796013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.